文献速递运动医学关节外科

移植物直径与类型对前交叉韧带翻修率的预测:瑞典与挪威国家登记研究

Graft Diameter and Graft Type as Predictors of Anterior Cruciate Ligament Revision: A Cohort Study Including 18,425 Patients from the Swedish and Norwegian National Knee Ligament Registries.
PubMed 文献 · J Bone Joint Surg Am · 2019-01-01

该回顾性队列研究基于瑞典和挪威国家膝关节韧带登记系统2004至2014年前交叉韧带(ACL)重建患者数据,纳入18,425例,分析腘绳肌腱(HT)与骨-髌腱-骨(PT)自体移植物直径对2年翻修率的影响。结果显示HT直径<8 mm者翻修风险高于更大直径HT(RR=1.25,95%CI 1.01–1.57),HT直径≥9.0 mm或≥10.0 mm者翻修风险低于PT。

要点

  • HT自体移植物直径<8 mm与更大直径HT相比,2年ACL翻修风险升高(RR=1.25,95%CI 1.01–1.57)。
  • HT直径≥9.0 mm或≥10.0 mm者早期翻修风险低于PT自体移植物。
  • PT与HT总体2年翻修率无显著差异(2.63% vs 2.08%,RR=0.93,95%CI 0.60–1.45)。

核心结论

  • 接受较大直径HT自体移植物的患者早期ACL翻修风险低于接受直径<8 mm HT者。
  • 接受HT直径≥9 mm或≥10 mm者的早期ACL翻修风险低于接受PT自体移植物者。

研究设计与样本

  • 回顾性研究,基于挪威和瑞典国家膝关节韧带登记系统前瞻性收集的数据。
  • 纳入2004至2014年期间接受初次ACL重建的患者,共18,425例(自58,692例中筛选)。
  • 主要终点为2年ACL翻修发生率,采用广义线性模型(二项分布、对数链接函数)估计相对风险(RR)及95%CI。

主要发现

  • 总体2年ACL翻修率为2.10%;PT自体移植物为2.63%,HT自体移植物为2.08%(RR=0.93,95%CI 0.60–1.45)。
  • HT自体移植物直径<8 mm者与更大直径HT相比,ACL翻修风险升高(RR=1.25,95%CI 1.01–1.57)。
  • HT自体移植物直径≥9.0 mm或≥10.0 mm者与PT自体移植物相比,早期ACL翻修风险降低。

关键数值与推荐

  • HT直径<8 mm vs 更大HT:RR=1.25(95%CI 1.01–1.57)。
  • HT vs PT总体:RR=0.93(95%CI 0.60–1.45)。
  • PT 2年翻修率2.63% vs HT 2.08%。
  • 证据等级:治疗性Level III。

临床怎么用

  • 选择HT自体移植物时,直径<8 mm与早期翻修风险升高相关,直径≥9.0 mm或≥10.0 mm与低于PT的早期翻修风险相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is important to investigate and compare graft diameters as well as graft types to identify risk factors for revision after an anterior cruciate ligament (ACL) reconstruction. We performed the current study in order to analyze the early ACL revision rate among patients treated with hamstring tendon (HT) autografts or patellar tendon (PT) autografts of different diameters. Our hypothesis was that an increase in both HT and PT autograft diameters would reduce the risk of early ACL revision. METHODS: This retrospective study was based on prospectively collected data from the national knee ligament registries of Norway and Sweden and included patients who underwent primary ACL reconstruction during the period of 2004 through 2014. The primary end point was the 2-year incidence of ACL revision. The impact of graft type and diameter on the incidence of revision surgery was reported as relative risks (RRs) with 95% confidence intervals (CIs), estimated by using generalized linear models with a binomial distribution and log-link function. RESULTS: Of 58,692 patients identified, a total of 18,425 patients were included in this study. The 2-year rate of ACL revision was 2.10% (PT autografts, 2.63%; HT autografts, 2.08%; RR = 0.93 [95% CI = 0.60 to 1.45]). There was an increased risk of ACL revision among patients treated with HT autografts with a diameter of <8 mm compared with larger HT autografts (RR = 1.25 [95% CI = 1.01 to 1.57]). Patients treated with HT autografts with a diameter of ≥9.0 mm or ≥10.0 mm had a reduced risk of early ACL revision compared with patients treated with PT autografts. CONCLUSIONS: Patients treated with larger-diameter HT autografts had a lower risk of early ACL revision compared with those treated with HT autografts of <8 mm. Patients treated with HT autografts of ≥9 or ≥10 mm had a reduced risk of early ACL revision compared with patients treated with PT autografts. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Snaebjörnsson T, Hamrin-Senorski E, Svantesson E, et al. Graft Diameter and Graft Type as Predictors of Anterior Cruciate Ligament Revision: A Cohort Study Including 18,425 Patients from the Swedish and Norwegian National Knee Ligament Registries. J Bone Joint Surg Am. 2019. PMID: 31626005. doi:10.2106/JBJS.18.01467

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。